Yazdani Reza, Hamidi Zahra, Babaha Fateme, Azizi Gholamreza, Fekrvand Saba, Abolhassani Hassan, Aghamohammadi Asghar
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, and the University of Medical Science, Tehran, Iran.
Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Endocr Metab Immune Disord Drug Targets. 2019;19(7):941-958. doi: 10.2174/1871530319666190225114739.
APDS [Activated phosphoinositide 3-kinase (PI3K) δ Syndrome] is a newly found special form of primary immunodeficiency caused by mutations in genes encoding PI3Kδ subunits and over-activation of the PI3K signaling pathway. Gain-of-function and loss-of-function mutations in PIK3CD (encoding P110δ) and PIK3R1 (encoding p85α, p55α and p50α) lead to APDS1 and APDS2, respectively. The subsequent irregular PI3K downstream signaling cascade is associated with abnormalities in B cells and T cells and the consequent heterogeneous clinical manifestations including respiratory tract infections, autoimmunity, lymphoproliferation and not to mention primary antibody deficiency. In this study, we report a 12-year-old girl with a mutation in the PIK3R1 gene who manifested immunological phenotypes resembling hyper IgM syndrome along with a review of the literature of the previously reported patients.
Whole exome sequencing was performed to detect the underlying genetic mutation in this patient.
A de novo heterozygous splice site mutation in the hot spot of the PIK3R1 gene within the intron 10 was found (c.1425+1G>A).
Further investigations are required for evaluation of the underlying genetic defects and the possible associations between genetic underpinning and heterogeneous severity and features of the disease.
活化磷脂酰肌醇3激酶(PI3K)δ综合征(APDS)是一种新发现的特殊形式的原发性免疫缺陷病,由编码PI3Kδ亚基的基因突变和PI3K信号通路过度激活引起。PIK3CD(编码P110δ)和PIK3R1(编码p85α、p55α和p50α)的功能获得性和功能丧失性突变分别导致APDS1和APDS2。随后PI3K下游信号级联反应异常与B细胞和T细胞异常以及随之而来的包括呼吸道感染、自身免疫、淋巴细胞增殖等异质性临床表现相关,更不用说原发性抗体缺陷了。在本研究中,我们报告了一名12岁女孩,其PIK3R1基因发生突变,表现出类似高IgM综合征的免疫表型,并对先前报道患者的文献进行了综述。
对该患者进行全外显子组测序以检测潜在的基因突变。
在内含子10的PIK3R1基因热点区域发现一个新发的杂合剪接位点突变(c.1425+1G>A)。
需要进一步研究以评估潜在的基因缺陷以及基因基础与疾病异质性严重程度和特征之间的可能关联。